FrankPintor
Registered
- Joined
- May 14, 2019
- Messages
- 1,931
- Likes
- 1,761
Combining vaccines is something to be taken very seriously, and studies are certainly the way to go, though I think "a few weeks" is a very optimistic target if clinical trials are going to be used. Nothing in the medical or scientific response to the pandemic has happened in a few weeks. Also, when a scientist tells you "there is no serious risk", he means exactly that, he doesn't mean that it will necessarily work. But then, who needs scientific studies when " la ciudad de Buenos Aires comenzará a instrumentar esta estrategia a mediados de agosto", as Infobae reports?1 July 2021 at 3:49am
What infectologist Roberto Debbag, the vice president of the Latin American Society of Pediatric Infectology, thinks about the combination of vaccines. The physician was optimistic and assured that, in a few weeks, the world will have new studies; in addition, he said with certainty that there is no serious risk when receiving different doses.Qué piensa el infectólogo Roberto Debbag sobre la combinación de vacunas
El médico se mostró optimista y aseguró que, en algunas semanas, el mundo contará con nuevos estudios; además, dijo con seguridad que no existe riesgo grave al recibir distintas dosiswww.lanacion.com.ar
He analyzed the global panorama of the vaccination campaign against Covid-19 and referred to recent studies on the combination of vaccines from different laboratories. “There are three groups that are studying some of the combinations, one is Oxford, and possibly in the second week of August there will be the data of the combination of AstraZeneca and Sputnik. In the United States, there are other combinations as well. Another was published in Spain, with a combination of Pfizer and AstraZeneca. For Sputnik we only have the potential Oxford study, that is why the need to have these studies in Argentina ”....
....Along these lines, he highlighted the importance of conducting linear studies in ARG in order to accelerate the vaccination campaign. “The prospects for vaccine arrivals are very good. If we now have AstraZeneca vaccines available and more Sinopharm vaccines arrive, immediately we must carry out studies that consist of applying a dose of AstraZeneca or Sinopharm to those who have already received the first and studying immunity after 21 days ”....